Beyond HER2: recent advances and future directions in targeted therapies in esophagogastric cancers

by Hwang, Jimmy
Published in J Gastrointest Oncol (2016)

Adjuvant therapy in biliary tract and gall bladder carcinomas: a review

by Prabhu, Roshan S., Hwang, Jimmy
Published in J Gastrointest Oncol (2017)

Continuum of care with anti-angiogenic therapies in metastatic colorectal cancer

by Smaglo, Brandon G., Hwang, Jimmy
Published 2013

Optimizing the management of hepatobiliary neoplasms: a multidisciplinary and molecular challenge

by Kadakia, Kunal C., Hwang, Jimmy J.
Published in J Gastrointest Oncol (2017)

A portable survivorship care plan: a tool that helps educate and improve knowledge in childhood cancer survivors

by Murphy, Patricia, Levine, Alyssa, Lerma, Tanya, Young, Sabrina, Hwang, Jimmy, Goldsby, Robert
Published in Support Care Cancer (2020)

Virological responses of treatment-naïve stage CDC-2 HIV-1 positive subjects receiving VGV-1 injections in a blinded, placebo-controlled, multi-centre clinical trial

by Noveljic, Zoja, Zhabilov, Harry, Hwang, Jimmy, Clark, Anel, Louw, AnneRika, Wright, Timothy, Bouic, Patrick
Published 2006

Healthy Colon, Healthy Life (Colon Sano, Vida Sana): Colorectal Cancer Screening Among Latinos in Santa Clara, California

by Walsh, Judith M. E., Salazar, René, Kaplan, Celia, Nguyen, Lamkieu, Hwang, Jimmy, Pasick, Rena J.
Published 2010

Dual-Energy X-ray Absorptiometry With Serum Ferritin Predicts Liver Iron Concentration and Changes in Concentration Better Than Ferritin Alone

by Shepherd, John A., Fan, Bo, Lu, Ying, Marquez, Lorena, Salama, Khaled, Hwang, Jimmy, Fung, Ellen B.
Published in J Clin Densitom (2010)

Immuno‐Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD‐L1 Testing May Not Be Enough

by Weinberg, Benjamin A., Xiu, Joanne, Hwang, Jimmy J., Shields, Anthony F., Salem, Mohamed E., Marshall, John L.
Published in Oncologist (2018)

Immunoprevention of Basal Cell Carcinomas with Recombinant Hedgehog-interacting Protein

by Vogt, Annika, Chuang, Pao-Tien, Hebert, Jennifer, Hwang, Jimmy, Lu, Ying, Kopelovich, Levy, Athar, Mohammad, Bickers, David R., Epstein, Ervin H.
Published 2004

Maintenance Therapy With Capecitabine in Patients With Resected Pancreatic Adenocarcinoma After Adjuvant Therapy: A Retrospective Cohort Study

by Weinberg, Benjamin A., Wang, Hongkun, Yang, Xuezhong, Wu, Christina S., Pishvaian, Michael J., He, Aiwu R., Marshall, John L., Hwang, Jimmy J.
Published 2014

Healthy Colon, Healthy Life: A Novel Colorectal Cancer Screening Intervention

by Walsh, Judith M.E., Salazar, Rene, Nguyen, Tung T., Kaplan, Celia, Nguyen, Lamkieu, Hwang, Jimmy, McPhee, Stephen J., Pasick, Rena J.
Published in Am J Prev Med (2010)

Molecular characteristics of hepatocellular carcinomas from different age groups

by Ang, Celina, Shields, Anthony, Xiu, Joanne, Gatalica, Zoran, Reddy, Sandeep, Salem, Mohamed E., Farhangfar, Carol, Hwang, Jimmy, Astsaturov, Igor, Marshall, John L.
Published in Oncotarget (2017)

Clinical and molecular features of papillary thyroid cancer in adolescents and young adults

by Vriens, Menno R, Moses, Willieford, Weng, Julie, Peng, Miao, Griffin, Ann, Bleyer, Archie, Pollock, Brad H, Indelicato, Daniel J., Hwang, Jimmy, Kebebew, Electron
Published 2010

Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients with Advanced Solid Tumors or Lymphoma

by Hwang, Jimmy J., Kuruvilla, John, Mendelson, David, Pishvaian, Michael J., Deeken, J.F., Siu, Lillian L., Berger, Mark S., Viallet, Jean, Marshall, John L.
Published 2010

A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies

by Lynce, Filipa, Wang, Hongkun, Petricoin, Emanuel F., Pohlmann, Paula R., Smaglo, Brandon, Hwang, Jimmy, He, Aiwu R., Subramaniam, Deepa, Deeken, John, Marshall, John, Pishvaian, Michael J.
Published in Cancer Chemother Pharmacol (2019)

A Phase I, open-label, dose escalation study of afatinib, in a 3-week-on/1-week-off schedule in patients with advanced solid tumors

by Marshall, John, Hwang, Jimmy, Eskens, Ferry A. L. M., Burger, Herman, Malik, Shakun, Uttenreuther-Fischer, Martina, Stopfer, Peter, Ould-Kaci, Mahmoud, Cohen, Roger B., Lewis, Nancy L
Published 2012

A Phase I Study of Cetuximab and Lapatinib In Patients with Advanced Solid Tumor Malignancies

by Deeken, John F., Wang, Hongkun, Subramaniam, Deepa, He, Aiwu Ruth, Hwang, Jimmy, Marshall, John L., Urso, Christina E., Wang, Yiru, Ramos, Corinne, Steadman, Kenneth, Pishvaian, Michael J.
Published in Cancer (2015)

Phase II Study of Everolimus in Patients With Metastatic Colorectal Adenocarcinoma Previously Treated With Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regim...

by Ng, Kimmie, Tabernero, Josep, Hwang, Jimmy, Bajetta, Emilio, Sharma, Sunil, Del Prete, Salvatore A., Arrowsmith, Edward R., Ryan, David P., Sedova, Michaela, Jin, Jin, Malek, Kamel, Fuchs, Charles S.
Published 2013

Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers

by Salem, Mohamed E., Weinberg, Benjamin A., Xiu, Joanne, El-Deiry, Wafik S., Hwang, Jimmy J., Gatalica, Zoran, Philip, Philip A., Shields, Anthony F., Lenz, Heinz-Josef, Marshall, John L.
Published in Oncotarget (2017)